Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
LeadershipIn this exclusive interview with the Female Motivational Speakers Agency, Thea discusses how the British beauty industry has changed since the late 1990s, why customers now expect brands to be more honest, the reality of raising money as a female founder, and
FinanceMost people looking to buy a house in the near future will also have to review the market for suitable loans.
NewsIf you own a small business, you know how hard it can be to stand out from the crowd. An excellent way to boost your business is through SEO tactics that will help increase online visibility in search engines.
StrategyCould yelp go up for sale? Customer feedback and review site, Yelp, struggles with slow growth.
StrategyAmid an improving global economy, the market for deals remains healthy, but CFOs’ outlook on M&A has leveled off somewhat since 2014.
FinanceMajority of B2B Companies Missing Out on Revenue Growth Due to Poor Customer Experience Performance, Accenture Study Finds
FinanceFranchising is the granting of a license by a franchisor to a franchisee, which entitles the franchisee to operate their own business using the franchisor’s brand, systems, knowhow and business model.
FinanceSaving for retirement is a distant prospect that only becomes real the closer we get to it, wishing we had started to save seriously earlier. However, could this be about to change for many?
InnovationSolabsen is one of the first privately owned laboratory in Senegal specialised in medical testing. We are very grateful to Dr Jean Francois ROBERT who first introduced our services in Senegal under a different trading name “Laboratoire ESPLAN” 40 years ago
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
